Topics

Phillips-Medisize Wins Contract to Manufacture First Electronic-Enabled Combination Drug Delivery Product

11:30 EDT 22 Oct 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Phillips-Medisize, a Molex company, announced today an agreement with a leading biotechnology company to manufacture a wearable, electronic-enabled combination product. The product is a post-phase III development-stage combination drug and device that com...

Other Sources for this Article

For more information, contact:
Heather Ditzler
Phone +1 715-377-7261
heather.ditzler@phillipsmedisize.com

Paula Kasper (Europe)
Phone +41448383933
paula.kasper@phillipsmedisize.com

NEXT ARTICLE

More From BioPortfolio on "Phillips-Medisize Wins Contract to Manufacture First Electronic-Enabled Combination Drug Delivery Product "

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...